Publications
-
Vector-borne disease is a common cause of hospitalized febrile illness in India
Citation: Robinson ML, Kadam D, Khadse S, Balasubramanian U, Raichur P, Valvi C, Marbaniang I, Kanade S, Sachs J, Basavaraj A, Bharadwaj R, Kagal A, Kulkarni V, Zenilman J, Nelson G, Manabe YC, Kinikar A, Gupta A, Mave V. Vector-borne disease is a common cause of hospitalized febrile illness in India. Am J Trop Med Hyg. 2018 Mar 26. doi: 10.4269/ajtmh.17-0571. [Epub ahead of print] PMCID: PMC5953363.
Date: 03/26/2018
Loss to follow‐up and mortality among HIV‐infected adolescents receiving antiretroviral therapy in
Citation: Nimkar S, Valvi C, Kadam D, Rewari BB, Kinikar A, Gupte N, Suryavanshi N, Deluca A, Shankar A, Golub J, Bollinger R, Gupta A, Marbaniang I, Mave V. Loss to follow‐up and mortality among HIV‐infected adolescents receiving antiretroviral therapy in Pune, India. HIV Med. 2018 Jul;19(6):395-402. doi: 10.1111/hiv.12605. Epub 2018 Mar 24. PMID: 29573312 PMCID. PMC6082173 [Available on 2019-07-01].
Date: 03/24/2018
B and T cell phenotypic profiles of African HIV-infected and HIV-exposed uninfected infants:
Citation: Weinberg A, Lindsey J, Bosch R, Persaud D, Sato P, Ogwu A, Asmelash A, Bwakura-Dangarambezi M, Chi BH, Canniff J, Lockman S, Simani G, Sikhuilile M, Smith CE, Moraka NO and Levin MJ. B and T cell phenotypic profiles of African HIV-infected and HIV-exposed uninfected infants: associations with antibody responses to the pentavalent rotavirus vaccine. Front Immunol. 2018 Jan 19;8:2002. PMID: 29403482; PMCID: PMC5780413
Date: 01/19/2018
Gender-based violence screening methods preferred by women visiting a public hospital in Pune, India
Citation: Suryavanshi N, Naik S, Waghmare S, Gupte N, Khan S, Mave V, Deluca A, Gupta A, Golub J, Bollinger RC, Shankar A. Gender-based violence screening methods preferred by women visiting a public hospital in Pune, India. BMC Womens Health. 2018 Jan 15;18(1):19. doi: 10.1186/s12905-018-0515-2. PMID: 29334936. PMCID: PMC5769341.
Date: 01/15/2018
Vitamin D3 supplementation increases spine bone mineral density in adolescents and young adults with
Citation: Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Harris DR, Price G, Baker A, Meyer WA 3rd, Wilson CM, Hazra R, Kapogiannis BG, Mulligan K; Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 109 Study Team. Vitamin D3 supplementation increases spine bone mineral density in adolescents and young adults with human immunodeficiency deficiency virus infection being treated with tenofovir disoproxil fumarate: A randomized, placebo-controlled trial. Clin Infect Dis. 2018 Jan 6;66(2):220-228. doi: 10.1093/cid/cix753. PMID: 29020329; PMCID: PMC5848310
Date: 01/06/2018
Suboptimal antituberculosis drug concentrations and outcomes in small and HIV‐coinfected children in
Citation: Bhavani PK, Gangadevi NP, Swaminathan S, Gupta A, Dooley KE, Savic RM. Suboptimal antituberculosis drug concentrations and outcomes in small and HIV-coinfected children in India: Recommendations for dose modifications. Guiastrennec B, Ramachandran G, Karlsson MO, Kumar AKH, Clin Pharmacol Ther. 2017 Dec 16. doi: 10.1002/cpt.987. [Epub ahead of print]. PMID: 29247506 PMCID: PMC6004234.
Date: 12/16/2017
Vitamin D supplementation does not affect metabolic changes seen with ART initiation
Citation: Muhammed J, Chan ES, Brown TT, Tebas P, McComsey GA, Melbourne K, Hardin R, Willig AL, Yin MT, Ribaudo H, Overton ET. Vitamin D supplementation does not affect metabolic changes seen with ART initiation. Open Forum Infect Dis. 2017 Dec 11;4(4):ofx210. doi: 10.1093/ofid/ofx210. eCollection 2017 Fall. PMID: 29255724. PMCID: PMC5726464
Date: 12/11/2017
Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with
Citation: Mave V, Kinikar A, Kagal A, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Gerona R, Wen A, Ramachandran G, Kumar H, Bacchetti P, Dooley KE, Gupte N, Gupta A, Gandhi M. Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis. PLoS One. 2017 Dec 7;12(12):e0189101. doi: 10.1371/journal.pone.0189101. eCollection 2017. PMID: 29216273. PMCID: PMC5720757.
Date: 12/07/2017
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults
Citation: Bisson GP, Ramchandani R, Miyahara S, Mngqibisa R, Matoga M, Ngongondo M, Samaneka W, Koech L, Naidoo K, Rassool M, Kirui F, Banda P, Mave V, Kadam D, Leger P, Henestroza G, Manabe YC, Bao J, Kumwenda J, Gupta A, Hosseinipour MC; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team. Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults. AIDS. 2017 Oct 23;31(16):2217-2225. doi: 10.1097/QAD.0000000000001606. PMID: 28742529; PMCID: PMC5633516
Date: 10/23/2017
Prospective analysis of lipid composition changes with antiretroviral therapy and immune activation
Citation: Belury MA, Bowman E, Gabriel J, Snyder B, Kulkarni M, Palettas M, Mo X, Lake JE, Zidar D, Sieg SF, Rodriguez B, Playford MP, Andrade A, Kuritzkes DR, Mehta NN, Lederman MM, Funderburg NT. Prospective analysis of lipid composition changes with antiretroviral therapy and immune activation in persons living with HIV. Pathog Immun. 2017;2(3):376-403. doi: 10.20411/pai.v2i3.218. Epub 2017 Oct 6. PMID: 29098203; PMCID: PMC5663243
Date: 10/06/2017
- ‹ First < 7 8 9 10 11 > Last ›